2001 to 2016 Saw Large Increase in Mohs Surgery for Melanoma
Regional variation considerable, with more than threefold variation between regions with highest, lowest use.
Melanoma
The Role of Metastasectomy for Melanoma Reexamined in the Modern Era
In the modern era of therapeutic agents, metastasectomy was still associated with improved survival outcomes for patients with stage IV melanoma.
TKI Combination vs Monotherapy for Advanced Melanoma and the Risk for CV Adverse Events
A meta-analysis sought to determine if survival is improved with dual targeting of the MAPK pathway with BRAF and MEK inhibitors vs BRAF inhibition alone in patients with advanced melanoma.
Rozlytrek, a Tumor Agnostic Therapy, Receives FDA Approval
The Food and Drug Administration (FDA) has granted accelerated approval to Rozlytrek (entrectinib; Genentech)
Does Adhering to the Mediterranean Diet Lower the Risk of Skin Cancer?
Researchers examined whether adhering to the Mediterranean diet reduces the risk of skin cancer. We review their findings.
Death Rates in Melanoma Fell Markedly Following the Proliferation of New Types of Therapies
Patients are now able to get immunotherapies and targeted therapies at their local clinics, rather than having to travel to academic medical centers.
Determining Risk Factors for Recurrence of Primary Localized Cutaneous Melanoma
Researchers sought to determine the risk of disease recurrence in patients with localized melanoma at high risk of disease metastasis.
Machine Versus Physician: Assigning Diagnoses to Pigmented Skin Lesions
Approximately one half of all biopsied/excised lesions from patients who have sun-damaged skin are nonmelanocytic.
Lack of Confidence in Undertaking Skin Self-Examinations in Patients With Melanoma
Efforts to integrate new digital technologies to increase regular and thorough skin self-examination for patients with melanoma are warranted, provided sufficient technical support is provided.
Time Between Initial Surgery and First Distant Recurrence Not Predictive of Response to Systemic Therapy in Metastatic Melanoma
With the exception of those enrolled in a clinical trial, all patients in this study received systemic monotherapy as first-line treatment of metastatic melanoma.
Next post in Melanoma
